Infección por SARS-CoV-2 en pacientes con enfermedad renal crónica en hemodiálisis. Evolución de la PCR de SARS-CoV-2

Zúñiga, José; Toapanta, Néstor; Ramos, Natalia; Caparros, Sonia; León-Roman, Juan; Azancot, María; Garcia-Carro, Clara; Espinel, Eugenia; Seron, Daniel; Soler, María José.
Nefrología (Madrid) ; 41(4): 476-478, jul.-ago. 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-227924

Documentos relacionados

  1. Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis.
  2. Change in estimated glomerular filtration rate and outcomes in chronic kidney disease.
  3. Relationship between selection of dosage forms of vitamin D receptor activators and short-term survival of patients on hemodialysis.
  4. The effect of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use on mortality in patients with chronic kidney disease: a meta-analysis of observational studies.
  5. Allopurinol Initiation and All-Cause Mortality Among Patients With Gout and Concurrent Chronic Kidney Disease : A Population-Based Cohort Study.
  6. Integrating risk prediction models into chronic kidney disease care.
  7. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.
  8. Repurposing drugs for diseases associated with podocyte dysfunction.
  9. Chronic kidney disease.
  10. Renin-Angiotensin System Blockade Is Associated with Exercise Capacity, Sympathetic Activity, and Endothelial Function in Patients with Chronic Kidney Disease.